These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3335317)

  • 1. Metabolic bone disease in primary biliary cirrhosis at presentation.
    Mitchison HC; Malcolm AJ; Bassendine MF; James OF
    Gastroenterology; 1988 Feb; 94(2):463-70. PubMed ID: 3335317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease.
    Bengoa JM; Sitrin MD; Meredith S; Kelly SE; Shah N; Baker AL; Rosenberg IH
    Hepatology; 1984; 4(2):261-5. PubMed ID: 6706300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D.
    Herlong HF; Recker RR; Maddrey WC
    Gastroenterology; 1982 Jul; 83(1 Pt 1):103-8. PubMed ID: 6978827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D, parathyroid hormone, and bone mineral content of lumbar spine and femur in primary biliary cirrhosis.
    Almdal T; Schaadt O; Vesterdad Jørgensen J; Lindgreen P; Ranek L
    J Intern Med; 1989 Mar; 225(3):207-13. PubMed ID: 2703802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis.
    Guañabens N; Parés A; Mariñoso L; Brancós MA; Piera C; Serrano S; Rivera F; Rodés J
    Am J Gastroenterol; 1990 Oct; 85(10):1356-62. PubMed ID: 2220729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Bone Disease in Primary Biliary Cirrhosis.
    Glass LM; Su GL
    Gastroenterol Clin North Am; 2016 Jun; 45(2):333-43. PubMed ID: 27261902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia.
    Cuthbert JA; Pak CY; Zerwekh JE; Glass KD; Combes B
    Hepatology; 1984; 4(1):1-8. PubMed ID: 6693061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low bone turnover state in primary biliary cirrhosis.
    Stellon AJ; Webb A; Compston J; Williams R
    Hepatology; 1987; 7(1):137-42. PubMed ID: 3804193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.
    Matloff DS; Kaplan MM; Neer RM; Goldberg MJ; Bitman W; Wolfe HJ
    Gastroenterology; 1982 Jul; 83(1 Pt 1):97-102. PubMed ID: 7075948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment.
    Floreani A; Chiaramonte M; Giannini S; Malvasi L; Lodetti MG; Castrignano R; Giacomini A; D'Angelo A; Naccarato R
    J Hepatol; 1991 Mar; 12(2):217-23. PubMed ID: 2051000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis.
    Verma A; Maxwell JD; Ang L; Davis T; Hodges S; Northfield TC; Zaidi M; Pazianas M
    Osteoporos Int; 2002 Aug; 13(8):677-82. PubMed ID: 12181628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss.
    Mitchison HC; Bassendine MF; Malcolm AJ; Watson AJ; Record CO; James OF
    Hepatology; 1989 Oct; 10(4):420-9. PubMed ID: 2777203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.
    Camisasca M; Crosignani A; Battezzati PM; Albisetti W; Grandinetti G; Pietrogrande L; Biffi A; Zuin M; Podda M
    Hepatology; 1994 Sep; 20(3):633-7. PubMed ID: 8076921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia.
    Orwoll ES; Meier DE
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1262-9. PubMed ID: 3023418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
    Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
    Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy.
    Kehayoglou AK; Holdsworth CD; Agnew JE; Whelton MJ; Sherlock S
    Lancet; 1968 Apr; 1(7545):715-8. PubMed ID: 4170960
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of osteomalacia in chronic cholestatic liver disease.
    Stellon AJ; Webb A; Compston J; Williams R
    Bone; 1986; 7(3):181-5. PubMed ID: 3768195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D.
    Reed JS; Meredith SC; Nemchausky BA; Rosenberg IH; Boyer JL
    Gastroenterology; 1980 Mar; 78(3):512-7. PubMed ID: 7351289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
    Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
    Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone loss and reduced osteoblast function in primary biliary cirrhosis.
    Hodgson SF; Dickson ER; Wahner HW; Johnson KA; Mann KG; Riggs BL
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):855-60. PubMed ID: 4062087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.